These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 26671269

  • 1. Ceftazidime/Avibactam: A New Antibiotic for Gram-Negative Infections.
    Chahine EB, Sourial M, Ortiz R.
    Consult Pharm; 2015 Dec; 30(12):695-705. PubMed ID: 26671269
    [Abstract] [Full Text] [Related]

  • 2. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
    Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB.
    Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
    [Abstract] [Full Text] [Related]

  • 3. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R, Park TE, Moy S.
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.
    Nicolau DP.
    Expert Opin Investig Drugs; 2015 Mar; 24(9):1261-73. PubMed ID: 26145447
    [Abstract] [Full Text] [Related]

  • 6. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.
    Falcone M, Paterson D.
    J Antimicrob Chemother; 2016 Oct; 71(10):2713-22. PubMed ID: 27432599
    [Abstract] [Full Text] [Related]

  • 7. The β-Lactams Strike Back: Ceftazidime-Avibactam.
    Zasowski EJ, Rybak JM, Rybak MJ.
    Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
    [Abstract] [Full Text] [Related]

  • 8. Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections.
    Buckman SA, Krekel T, Muller AE, Mazuski JE.
    Expert Opin Pharmacother; 2016 Dec; 17(17):2341-2349. PubMed ID: 27758148
    [Abstract] [Full Text] [Related]

  • 9. Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections.
    Shirley M.
    Drugs; 2018 Apr; 78(6):675-692. PubMed ID: 29671219
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.
    Zhong H, Zhao XY, Zhang ZL, Gu ZC, Zhang C, Gao Y, Cui M.
    Int J Antimicrob Agents; 2018 Oct; 52(4):443-450. PubMed ID: 30012440
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Qin X, Tran BG, Kim MJ, Wang L, Nguyen DA, Chen Q, Song J, Laud PJ, Stone GG, Chow JW.
    Int J Antimicrob Agents; 2017 May; 49(5):579-588. PubMed ID: 28363526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme.
    Cheng K, Newell P, Chow JW, Broadhurst H, Wilson D, Yates K, Wardman A.
    Drug Saf; 2020 Aug; 43(8):751-766. PubMed ID: 32602065
    [Abstract] [Full Text] [Related]

  • 15. Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
    Hidalgo JA, Vinluan CM, Antony N.
    Drug Des Devel Ther; 2016 Aug; 10():2379-86. PubMed ID: 27528799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial.
    Lucasti C, Popescu I, Ramesh MK, Lipka J, Sable C.
    J Antimicrob Chemother; 2013 May; 68(5):1183-92. PubMed ID: 23391714
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections.
    Alidjanov JF, Fritzenwanker M, Hoffman I, Wagenlehner FM.
    Future Microbiol; 2017 Jun; 12():655-670. PubMed ID: 28338347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.